Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

The MBNL/CELF Splicing Factors Regulate Cytosolic Sulfotransferase 4A1 Protein Expression during Cell Differentiation

Misgana Idris, Neville J. Butcher and Rodney F. Minchin
Drug Metabolism and Disposition March 2019, 47 (3) 314-319; DOI: https://doi.org/10.1124/dmd.118.085290
Misgana Idris
Laboratory for Molecular and Cellular Pharmacology, School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neville J. Butcher
Laboratory for Molecular and Cellular Pharmacology, School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Neville J. Butcher
Rodney F. Minchin
Laboratory for Molecular and Cellular Pharmacology, School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rodney F. Minchin
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    SULT4A1 transcript and protein expression during cell differentiation and mouse embryonic development. (A) SH-SY5Y cells were cultured for up to 12 days in Dulbecco’s modified Eagle’s medium/F12 medium in the presence of 10 µM RA. At each time point, cells were harvested for mRNA and protein determination. RT-PCR was performed using primers located in exon 6 and exon 7. The variant transcript, which contained pseudo-exon 6p, produced a PCR product of 397 bp, whereas the WT transcript produced a PCR product of 270 bp. RT-PCR results are shown in the upper two images, whereas SULT4A1 protein is shown in the lower two images. (B) SULT4A1 mRNA and protein in hiPSCs during RA-induced differentiation. (C) Expression of SULT4A1 mRNA and protein in mouse embryonic tissue from day E8.5 to E18.5. β-actin was used as a housekeeping gene for RT-PCR and α-tubulin as a loading control for Western blots. Molecular weight markers are shown on the right of each Western blot.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Minigene splicing assay of SULT4A1 pseudo-exon 6p in SH-SY5Y cells differentiated with RA. (A) Deletion minigene assays: 10 minigene plasmids with sequential deletion of intronic segments of the approximately 1.6 kb full-length minigene were constructed and transfected into SH-SY5Y cells with and without RA treatment. Switching of the endogenous SULT4A1 transcript was used as a positive control (far right panels). The nomenclature of the deletion minigenes is based on the number of base pairs deleted from either the 5′ or 3′ ends of the full-length minigene. RA untreated (−) and treated (+) lanes are labeled and the ratio of the variant to the WT PCR product (V/WT) is shown next to the RT-PCR gels. Results are representative of duplicate experiments. (B) Sequence of the SULT4A1 gene upstream of pseudo-exon 6p (gray arrow) showing the 32-base sequence between 5′Δ406 and 5′Δ438 (red). Putative binding motifs for RNA processing factors are shown in the boxes with blue (MBNL) and green (CELF). Numbers refer to the number of bases upstream of the 6p pseudo-exon. (C) Effect of ectopic expression of the MBNL and CELF genes on splicing of the 5′Δ338 minigene construct in undifferentiated SH-SY5Y cells. Cells were transfected with each RNA splicing factor and the minigene. The upper panel shows the PCR products of the minigene transcript with the variant and WT indicated. Expression of each protein is shown as a FLAG Western blot below. (D) Effect of MBNL and CELF proteins on the splicing of endogenous SULT4A1 in undifferentiated SH-SY-5Y cells. The upper panel shows the variant and WT PCR products. Expression of each protein is shown as a FLAG Western blot below. Results are representative of duplicate experiments. Molecular weight markers are shown on the right of each Western blot. EV, empty vector.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Expression of SULT4A1, MBNL, and CELF transcripts in SH-SY5Y cells during RA-induced differentiation. (A) SH-SY5Y cells were treated with 10 µM RA for 10 days. RNA was isolated at the indicated times and amplified by RT-PCR. For MBNL-2, splice variants were detected. (B) Western blots of protein expression after 10 days of RA treatment. Quantification of protein levels is shown alongside each Western blot. Data are the mean ± S.D. (n = 3). *P < 0.05 (significant differences, t test). CTRL, control.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Expression of MBNL and CELF proteins in hiPSCs during neuronal differentiation with 10 µM RA. Proteins were identified by Western blots and quantified by densitometry as the ratio of protein to α-tubulin (MBNL proteins) or β-actin (CELF proteins). Molecular weight markers are shown on the right of each Western blot. For MBNL-1 and MBNL-2, closed symbols are the upper band and open symbols are the lower band.

Additional Files

  • Figures
  • Data Supplement

    • Supplemental Data -

      2 supplemental figures, 2 tables. 

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 47 (3)
Drug Metabolism and Disposition
Vol. 47, Issue 3
1 Mar 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The MBNL/CELF Splicing Factors Regulate Cytosolic Sulfotransferase 4A1 Protein Expression during Cell Differentiation
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

Role of MBNL and CELF in SULT4A1 Splicing

Misgana Idris, Neville J. Butcher and Rodney F. Minchin
Drug Metabolism and Disposition March 1, 2019, 47 (3) 314-319; DOI: https://doi.org/10.1124/dmd.118.085290

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationShort Communication

Role of MBNL and CELF in SULT4A1 Splicing

Misgana Idris, Neville J. Butcher and Rodney F. Minchin
Drug Metabolism and Disposition March 1, 2019, 47 (3) 314-319; DOI: https://doi.org/10.1124/dmd.118.085290
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communication

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics